Canopy Growth, Indivior, and Tilray are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.
Canopy Growth (CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.
Shares of CGC traded down $0.08 during midday trading on Friday, reaching $1.41. 19,052,003 shares of the stock were exchanged, compared to its average volume of 6,771,341. The company has a quick ratio of 2.58, a current ratio of 3.52 and a debt-to-equity ratio of 0.74. The company has a market cap of $259.25 million, a P/E ratio of -0.37 and a beta of 0.92. Canopy Growth has a twelve month low of $0.77 and a twelve month high of $14.92. The stock's 50 day simple moving average is $1.16 and its 200 day simple moving average is $2.56.
Read Our Latest Research Report on CGC
Indivior (INDV)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Indivior stock traded up $0.80 during mid-day trading on Friday, reaching $11.56. 1,463,302 shares of the company were exchanged, compared to its average volume of 967,249. The company has a fifty day simple moving average of $9.48 and a 200-day simple moving average of $10.32. The firm has a market cap of $1.59 billion, a PE ratio of -33.03 and a beta of 0.93. Indivior has a 12 month low of $7.33 and a 12 month high of $18.59.
Read Our Latest Research Report on INDV
Tilray (TLRY)
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
TLRY stock traded down $0.01 during mid-day trading on Friday, hitting $0.49. The stock had a trading volume of 30,800,247 shares, compared to its average volume of 29,495,115. The firm has a fifty day simple moving average of $0.62 and a 200 day simple moving average of $1.09. The firm has a market capitalization of $490.26 million, a P/E ratio of -1.62 and a beta of 1.88. The company has a current ratio of 2.54, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Tilray has a 52 week low of $0.43 and a 52 week high of $2.52.
Read Our Latest Research Report on TLRY
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Canopy Growth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.
While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.